TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

Compounds that inhibit HIF-2a, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases disorders, and conditions, including cancer- and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DREW, Samuel Lawrie, EPPLIN, Matthew, MOON, Hyunyoung, LINDSEY, Erick Allen, LAWSON, Kenneth Victor, POWERS, Jay Patrick, BEATTY, Joel Worley, GAL, Balint, JACOB, Steven Donald, MAILYAN, Artur Karenovich, FOURNIER, Jeremy Thomas Andre, MANDAL, Debashis, LELETI, Manmohan Reddy, WANG, Zhang, KALISIAK, Jaroslaw, MATA, Guillaume, ROSEN, Brandon Reid, JEFFREY, Jenna Leigh, HAELSIG, Karl T, HARDMAN, Clayton, TRAN, Anh Thu, YU, Kai, SU, Yongli, GUNEY, Tezcan, YAN, Xuelei
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds that inhibit HIF-2a, and compositions containing the compound(s) and methods for synthesizing the compounds, are described herein. Also described are the use of such compounds and compositions for the treatment of a diverse array of diseases disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by HIF-2a. L'invention concerne des composés qui inhibent HIF-2α, et des compositions contenant le ou les composés et des procédés de synthèse des composés. L'invention concerne également l'utilisation de tels composés et compositions pour le traitement d'un réseau divers de maladies, de troubles et d'états, comprenant des troubles liés au cancer et à l'immunité qui sont médiés, au moins en partie, par HIF-2α.